Development and evaluation of next-generation cardiotoxicity assay based on embryonic stem cell-derived cardiomyocytes

In accordance with requirements of the ICH S7B safety pharma-cology guidelines, numerous next-generation cardiotoxicity studies using human stem cell-derived cardiomyocytes (CMs) are being conducted globally. Although several stem cell-derived CMs are being developed for commercialization, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Bokyeong, Choi, Seong Woo, Lee, Seul-Gi, Jeong, Young-Hoon, Kim, Ukjin, Kim, Jin, Jung, Cho-Rok, Chung, Hyung-Min, Park, Jae-Hak, Kim, C-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473479/
https://www.ncbi.nlm.nih.gov/pubmed/32336319
http://dx.doi.org/10.5483/BMBRep.2020.53.8.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473479/
https://www.ncbi.nlm.nih.gov/pubmed/32336319
http://dx.doi.org/10.5483/BMBRep.2020.53.8.022

Ejemplares similares